China gene-editing startup EdiGene has appointed Yun Li, MD, as vice president of clinical development. Li has more than 20 years' experience in clinical development of novel therapeutics, mainly focusing on oncology, hematology and immunology trials.
Before EdiGene, Li had been with Parexel International Corp. for over 10 years as medical director in the company's global medical service
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?